GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Simulations Plus Inc (NAS:SLP) » Definitions » Revenue

Simulations Plus (Simulations Plus) Revenue : $64.67 Mil (TTM As of Feb. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Simulations Plus Revenue?

Simulations Plus's revenue for the three months ended in Feb. 2024 was $18.31 Mil. Its revenue for the trailing twelve months (TTM) ended in Feb. 2024 was $64.67 Mil. Simulations Plus's Revenue per Share for the three months ended in Feb. 2024 was $0.90. Its Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was $3.18.

Good Sign:

Simulations Plus Inc has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Simulations Plus was 21.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 16.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Simulations Plus's highest 3-Year average Revenue per Share Growth Rate was 25.40% per year. The lowest was -28.30% per year. And the median was 10.05% per year.


Simulations Plus Revenue Historical Data

The historical data trend for Simulations Plus's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simulations Plus Revenue Chart

Simulations Plus Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.97 41.59 46.47 53.91 59.58

Simulations Plus Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.75 16.23 15.63 14.50 18.31

Competitive Comparison of Simulations Plus's Revenue

For the Health Information Services subindustry, Simulations Plus's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus's Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Revenue distribution charts can be found below:

* The bar in red indicates where Simulations Plus's Revenue falls into.



Simulations Plus Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $64.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Simulations Plus  (NAS:SLP) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Simulations Plus Revenue Related Terms

Thank you for viewing the detailed overview of Simulations Plus's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Simulations Plus (Simulations Plus) Business Description

Traded in Other Exchanges
N/A
Address
42505 Tenth Street West, Lancaster, CA, USA, 93534-7059
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
Executives
John Kenneth Paglia director 746 GRABLE PLACE, NEWBURY PARK CA 91320
Walter S Woltosz director, 10 percent owner, officer: Chairman and CEO 42505 10TH ST. WEST, LANCASTER CA 93534
Dibella John Anthony Ii officer: Division President 42505 10TH STREET WEST, LANCASTER CA 93534
Lisa Lavange director 42505 10TH ST., WEST, LANCASTER CA 93534
Steven Chang officer: President, Immunetrics 42505 10TH STREET WEST, LANCASTER CA 15203
Shawn Oconnor officer: Chief Executive Officer 42505 10TH STREET WEST, LANCASTER CA 93534-7059
Jill Fiedler-kelly officer: President, Cognigen Division 42505 10TH STREET WEST, LANCASTER CA 93534
Brett Howell officer: President, DILIsym Division 42505 10TH STREET WEST, LANCASTER CA 93534
William W Frederick officer: CFO C/O SIMULATIONS PLUS, INC., 42505 10TH STREET WEST, LANCASTER CA 93534
Daniel L Weiner director 800 WEST EL CAMINO REAL, SUITE 200, MOUNTAIN VIEW CA 94040
Sharlene Evans director 42505 10TH STREET WEST, LANCASTER CA 93534
Nguyen Nguyen officer: VP of Human Resources 42505 TENTH STREET WEST, LANCASTER CA 93534
David L. Ralph director 42505 10TH STREET WEST, LANCASTER CA 93534
John Robert Kneisel officer: CFO 42505 10TH STREET WEST, LANCASTER CA 93534
Grasela Thaddeus Henry Jr director, officer: President 1780 WEHRLE DRIVE SUITE 110, BUFFALO NY 14221